Today, the U.S. Food and Drug Administration announced it is investigating consumer complaints of Cronobacter sakazakii and Salmonella Newport infections.

On September 23, the Centers for Disease Control and Prevention (CDC) officially recommended a booster shot for individuals age 65 and older, as well as those between the ages of...

On June 7, the FDA granted accelerated approval for aducanumab (Aduhelm), the first drug approved to treat Alzheimer’s disease since 2003. However, there is limited evidence that this treatment will...

The FDA announced it is requesting manufacturers to withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.

At this time, the FDA has not authorized the sale of any at-home COVID-19 testing kits to consumers, but several companies announced they will be introducing at-home coronavirus tests.

FDA has requested that the manufacturer of Belviq, Belviq XR (lorcaserin) voluntarily withdraw the weight-loss drug from the U.S. market because a safety clinical trial shows an increased occurrence of...

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.